Related references
Note: Only part of the references are listed.Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome
Ulrika S. S. Petersen et al.
HUMAN MUTATION (2022)
Vulnerable exons, like ACADM exon 5, are highly dependent on maintaining a correct balance between splicing enhancers and silencers
Lise L. Holm et al.
HUMAN MUTATION (2022)
Addressing the Needs of Patients with Ultra-Rare Mutations One Patient at a Time: The n-Lorem Approach
Stanley T. Crooke
NUCLEIC ACID THERAPEUTICS (2022)
In silico identification of pseudo-exon activation events in personal genome and transcriptome data
Narumi Sakaguchi et al.
RNA BIOLOGY (2021)
Antisense technology: A review
Stanley T. Crooke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
RNA drugs custommade for rare diseases face wider test
Jocelyn Kaiser
SCIENCE (2021)
Spectrum of splicing variants in disease genes and the ability of RNA analysis to reduce uncertainty in clinical interpretation
Rebecca Truty et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2021)
Delivery of oligonucleotide-based therapeutics: challenges and opportunities
Suzan M. Hammond et al.
EMBO MOLECULAR MEDICINE (2021)
Molecular and metabolic bases of tetrahydrobiopterin (BH4) deficiencies
Nastassja Himmelreich et al.
MOLECULAR GENETICS AND METABOLISM (2021)
Nucleic acid delivery for therapeutic applications
Akash Gupta et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
N-of-1 drugs push biopharma frontiers
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2020)
Identification of new F8 deep intronic variations in patients with haemophilia A
Amy Dericquebourg et al.
HAEMOPHILIA (2020)
Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
Kian Huat Lim et al.
NATURE COMMUNICATIONS (2020)
Detailed Phenotyping and Therapeutic Strategies for Intronic ABCA4 Variants in Stargardt Disease
Mubeen Khan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Retrospective analysis of 19 patients with 6-Pyruvoyl Tetrahydropterin Synthase Deficiency: Prolactin levels inversely correlate with growth
Francesca Manzoni et al.
MOLECULAR GENETICS AND METABOLISM (2020)
A Generic Assay to Detect Aberrant ARSB Splicing and mRNA Degradation for the Molecular Diagnosis of MPS VI
Mike Broeders et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease (vol 104, pg 466, 2019)
Hernan D. Gonorazky et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Role of protein structure in variant annotation: structural insight of mutations causing 6-pyruvoyl-tetrahydropterin synthase deficiency
Joao R. C. Muniz et al.
PATHOLOGY (2019)
Nuclear TARBP2 Drives Oncogenic Dysregulation of RNA Splicing and Decay
Lisa Fish et al.
MOLECULAR CELL (2019)
Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts
Laure Fresard et al.
NATURE MEDICINE (2019)
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
J. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides
Riccardo Sangermano et al.
GENETICS IN MEDICINE (2019)
Identification and Rescue of Splice Defects Caused by Two Neighboring Deep-Intronic ABCA4 Mutations Underlying Stargardt Disease
Silvia Albert et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Reccurrent F8 Intronic Deletion Found in Mild Hemophilia A Causes Alu Exonization
Yohann Jourdy et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Genetic therapies for spinal muscular atrophy type 1
Annemieke Aartsma-Rus
LANCET NEUROLOGY (2018)
Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5′ splice site
Ainhoa Martinez-Pizarro et al.
PLOS GENETICS (2018)
Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation
L. Grodecka et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
Deep intronic mutations and human disease
Rita Vaz-Drago et al.
HUMAN GENETICS (2017)
Pathogenic variants that alter protein code often disrupt splicing
Rachel Soemedi et al.
NATURE GENETICS (2017)
Improving genetic diagnosis in Mendelian disease with transcriptome sequencing
Beryl B. Cummings et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Genetic diagnosis of Mendelian disorders via RNA sequencing
Laura S. Kremer et al.
NATURE COMMUNICATIONS (2017)
RNA splicing in human disease and in the clinic
Diana Baralle et al.
CLINICAL SCIENCE (2017)
RNA mis-splicing in disease
Marina M. Scotti et al.
NATURE REVIEWS GENETICS (2016)
Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing
Wen Xiao et al.
MOLECULAR CELL (2016)
Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP)
Eric L. Van Nostrand et al.
NATURE METHODS (2016)
Splice-shifting oligonucleotide (SSO) mediated blocking of an exonic splicing enhancer (ESE) created by the prevalent c.903+469T>C MTRR mutation corrects splicing and restores enzyme activity in patient cells
Bruno Palhais et al.
NUCLEIC ACIDS RESEARCH (2015)
Antisense Mediated Splicing Modulation For Inherited Metabolic Diseases: Challenges for Delivery
Belen Perez et al.
NUCLEIC ACID THERAPEUTICS (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Software for Computing and Annotating Genomic Ranges
Michael Lawrence et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Tetrahydrobiopterin: biochemistry and pathophysiology
Ernst R. Werner et al.
BIOCHEMICAL JOURNAL (2011)
Pseudoexon Exclusion by Antisense Therapy in 6-Pyruvoyl-Tetrahydropterin Synthase Deficiency
Sandra Brasil et al.
HUMAN MUTATION (2011)
Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies
Ashish Dhir et al.
FEBS JOURNAL (2010)
Transposable elements in disease-associated cryptic exons
Igor Vorechovsky
HUMAN GENETICS (2010)
The Deep Intronic c.903+469T>C Mutation in the MTRR Gene Creates an SF2/ASF Binding Exonic Splicing Enhancer, Which Leads to Pseudoexon Activation and Causes the cbIE Type of Homocystinuria
Katerina Homolova et al.
HUMAN MUTATION (2010)
Present and future of antisense therapy for splicing modulation in inherited metabolic disease
Belen Perez et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Disease-Causing Mutations Improving the Branch Site and Polypyrimidine Tract: Pseudoexon Activation of LINE-2 and Antisense Alu Lacking the Poly(T)-Tail
David Meili et al.
HUMAN MUTATION (2009)
Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms
Annemieke Aartsma-Rus et al.
MOLECULAR THERAPY (2009)
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Francois-Olivier Desmet et al.
NUCLEIC ACIDS RESEARCH (2009)
Comparative analysis of transposed element insertion within human and mouse genomes reveals Alu's unique role in shaping the human transcriptome
Noa Sela et al.
GENOME BIOLOGY (2007)
Minimal conditions for exonization of intronic sequences:: 5′ splice site formation in Alu exons
R Sorek et al.
MOLECULAR CELL (2004)
Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells
A Aartsma-Rus et al.
GENE THERAPY (2004)
Influence of RNA secondary structure on the pre-mRNA splicing process
E Buratti et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals
G Yeo et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2004)
Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise
JT Mendell et al.
NATURE GENETICS (2004)
ESEfinder: a web resource to identify exonic splicing enhancers
L Cartegni et al.
NUCLEIC ACIDS RESEARCH (2003)
Share Paper
